Ocular Therapeutix, Inc. (OCUL)
9.495
+0.26
(+2.76%)
USD |
NASDAQ |
May 14, 16:00
9.47
-0.02
(-0.26%)
After-Hours: 19:55
Ocular Therapeutix Total Liabilities (Quarterly) : 150.96M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint, Inc. | 57.74M |
| Merck & Co., Inc. | 82.75B |
| Zevra Therapeutics, Inc. | 72.78M |
| Axsome Therapeutics, Inc. | 659.02M |
| Bristol Myers Squibb Co. | 66.37B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 732.53M |
| Shareholders Equity (Quarterly) | 581.57M |
| Debt to Equity Ratio | 0.1366 |
| Current Ratio | 14.81 |
| Net Debt Paydown Yield | -0.04% |